SCHEMBL4551372

SCHEMBL4551372

O=C1CNCC(CCc2ccccc2)N1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TACR2 P21452 1/20 0.40
PLG P00747 1/20 0.38
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL682821 0.83 HDAC8 (0.45) TACR2HDAC8
SCHEMBL2088808 0.83 HDAC8 (0.45) TACR2HDAC8
SCHEMBL682465 0.83 HDAC8 (0.45) TACR2HDAC8
SCHEMBL31018491 0.78 MEN1 (0.44)
SCHEMBL31018488 0.78 MEN1 (0.44)
SCHEMBL6616396 0.78 MEN1 (0.44)
SCHEMBL31018502 0.78 MEN1 (0.44)
SCHEMBL22201266 0.77 DDB1 (0.45)
SCHEMBL22190368 0.77 DDB1 (0.45)
SCHEMBL11025726 0.77 TACR2 (0.44) TACR2PLG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016160677-A1 COMPOUNDS FOR THE TREATMENT OF ARENAVIRUS INFECTION ARISAN THERAPEUTICS INC. (US) 2016-10-06 WO disclosed
EP-2019819-A1 NOVEL PEPTIDE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS FOR TREATING WOUNDS Neobiotics AB (SE) 2009-02-04 EP disclosed
WO-2007129952-A1 NOVEL PEPTIDE DERIVATIVES USEFUL AS ANTIMICROBIAL AGENTS FOR TREATING WOUNDS NEOBIOTICS AB (SE) 2007-11-15 WO disclosed